$AMBS Stock Message Board and Forum http://invest
Post# of 250616

Stock Message Board and Forum http://investorshangout.com/search?q=AMBS&...mp;yt0=Go!
##### recent news/filings ~ source: finance.yahoo.com
Wed, 14 Aug 2013 13:02:00 GMT ~ Amarantus BioScience - “Ophthalmology: MANF’s Orphan Strategy Coming into Focus in Retinitis Pigmentosa”
- Amarantus BioScience, Inc. (OTCQB: AMBS) today published a new blog post on The Chairman’s Blog, written by the company’s President and CEO, Gerald Commissiong. TheChairmansBlog.com is an exclusive online ...
read full: http://finance.yahoo.com/news/amarantus-biosc...00710.html
*********************************************************
Mon, 12 Aug 2013 20:16:08 GMT ~ Amarantus Eyes Orphan Indication For MANF
read full: http://seekingalpha.com/article/1629912-amara...urce=yahoo
*********************************************************
Mon, 12 Aug 2013 13:21:05 GMT ~ Amarantus Announces Positive Orphan Data for MANF in Retinitis Pigmentosa
- SUNNYVALE, Calif. -- Amarantus BioScience Holdings, Inc. (OTCQB:AMBS), a biotechnology company discovering and developing treatments and diagnostics for diseases associated with neurodegeneration and apoptosis, ...
read full: http://finance.yahoo.com/news/amarantus-annou...05762.html
*********************************************************
Tue, 06 Aug 2013 20:16:34 GMT ~ AMARANTUS BIOSCIENCE HOLDINGS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
read full: http://biz.yahoo.com/e/130806/ambs8-k.html
*********************************************************
Tue, 06 Aug 2013 13:06:43 GMT ~ Amarantus Issues Mid-Year President's Letter to Shareholders
- SUNNYVALE, Calif. -- Amarantus BioScience Holdings, Inc. (OTCQB:AMBS), a biotechnology company discovering and developing treatments and diagnostics for diseases associated with neurodegeneration and apoptosis, ...
read full: http://finance.yahoo.com/news/amarantus-issue...43410.html
*********************************************************
##### chart ~ source: stockcharts.com
http://stockcharts.com/h-sc/ui?s=AMBS&p=D...3180572698
##### chart ~ source: eoddata.com
http://chart.eoddata.com/?e=OTCBB&s=AMBS&...D&b=BB
##### company info ~ source: otcmarkets.com
Link: http://www.otcmarkets.com/stock/AMBS/company-info
Ticker: $AMBS
OTC Market Place: OTCQB
CIK code: 0001424812
Company name: Amarantus Bioscience Holdings, Inc.
Company website: http://www.amarantus.com
Incorporated In: NV, USA
##### extra dd links
Edgar filings: http://www.sec.gov/cgi-bin/browse-edgar?actio...p;count=40
Latest filings: http://www.otcmarkets.com/stock/AMBS/filings
Latest financials: http://www.otcmarkets.com/stock/AMBS/financials
Latest news: http://www.otcmarkets.com/stock/AMBS/news - http://finance.yahoo.com/q/h?s=AMBS+Headlines
Major holdings: http://data.cnbc.com/quotes/AMBS/tab/8.1
Insider transactions (1): http://finance.yahoo.com/q/it?s=AMBS+Insider+Transactions
Insider transactions (2): http://www.secform4.com/insider-trading/AMBS.htm
Insider transactions (3): http://www.insidercow.com/history/company.jsp?company=AMBS
RegSho: http://www.regsho.com/tools/symbol_stats.php?...rch=search
DTCC: http://search2.dtcc.com/?q=Amarantus+Bioscien...ISO-8859-1
Spoke company information: http://www.spoke.com/search?utf8=%E2%9C%93&am...ngs%2C+Inc.
Corporation WIKI: http://www.corporationwiki.com/search/results...;y=0WHOIS: http://whois.domaintools.com/http://www.amarantus.com
Alexa: http://www.alexa.com/siteinfo/http://www.amarantus.com#
Corporate website internet archive: http://web.archive.org/web/*/http://www.amarantus.com
##### last known share structure ~ source: otcmarkets.com
Market Value: $12,782,105 a/o Aug 16, 2013
Shares Outstanding: 385,003,149 a/o May 16, 2013
Float: Not Available
Authorized Shares: 1,000,000,000 a/o Nov 14, 2012
Par Value: 0.001
##### business description ~ source: otcmarkets.com
Amarantus BioScience, Inc. is a development-stage biotechnology company founded in January 2008. The Company is focused on developing unique products and proprietary technologies for the potential treatment and/or diagnosis of Parkinson's disease, Alzheimer's disease, Traumatic Brain Injury, Ischemic Heart Disease and other human diseases. The Company owns the intellectual property rights to Mesencephalic-Astrocyte-derived Neurotrophic Factor (\
Stock Message Board and Forum http://investorshangout.com/search?q=AMBS&...mp;yt0=Go!

